Clinical Trial 45961

Long Beach, CA 90806


Summary:

This is a multi-center, randomized, double blind, active controlled clinical Study. Following a screening period, eligible subjects will be enrolled to an open-label oral IR LD/CD adjustment period; then an open-label ND0612 conversion period; then after optimization periods subjects will be randomized to receive either ND0612 or its matching Placebo with IR LD/CD.



Criteria:
  • Male and female patients, aged ≥30 years.
  • PD diagnosis consistent with the UK Brain Bank Criteria.
  • Modified Hoehn & Yahr score ≤3 during ON.
  • Average of ≥2.5 hours of OFF time (≥2 hours OFF every day) during waking hours as confirmed by patient diary over 3 days.
  • Taking ≥4 levodopa doses/day (≥3 doses/day of extended release LD/DDI, e.g.,Rytary®) at a total daily dose of ≥400mg.


Qualified Participants May Receive:

Compensation for participating up to $1,900 over the study length (5 months)


Available At:

Collaborative Neuroscience Research, LLC

Long Beach, CA 90806
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.